Levo Therapeutics, Inc. — Form D
Levo Therapeutics, Inc. of SKOKIE, IL, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-25. The offering totals $40.0M, of which $40.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-11-25
- Form: D
- Accession: 0001739074-19-000008
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $40.0M
- Investors: 4
- Date of first sale: 2019-09-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-354098
Issuer
- Name: Levo Therapeutics, Inc.
- CIK: 0001793935
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5215 OLD ORCHARD ROAD, SKOKIE, IL, 60077
- Phone: (847) 901-9260
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Sara Cotter | Director | Skokie, IL |
| Michael Dybbs | Director | Half Moon Bay, CA |
| Terrence Kearney | Director | Skokie, IL |
| Steven Ryder | Director | Skokie, IL |
| Daniel Welch | Director | Skokie, IL |
| Sara Cotter | Executive Officer | Skokie, IL |
| Sara Cotter | Promoter | Skokie, IL |
| Sara Brownstein | Director | Skokie, IL |
Other filings by this issuer (1)
More